Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

SYRESYRE
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in SPYRE THERAPEUTICS INC

JPMORGAN CHASE & CO holds 1.1M shares of SYRE (SPYRE THERAPEUTICS INC), worth $98.9M as of 2026-Q2. The position was increased (+11.6% shares). SYRE represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$98.9M

Current Shares

1.1M

Total Value Change

+$98.1M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+11.6%
$98.9M0.0%$88.78
33
2026-Q1
Increased
979,299
+1455.7%
$44.5M0.0%$40.07
47
2025-Q4
Decreased
62,951
-88.6%
$2.1M0.0%$31.88
0
2025-Q3
Increased
551,968
+1067.5%
$9.3M0.0%$16.36
45
2025-Q2
Increased
47,279
+13.8%
$707,7660.0%$15.22
19
2025-Q1
Increased
41,556
+17.9%
$670,5060.0%$17.94
20
2024-Q4
New
35,248
-
$820,5740.0%$22.54
34

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used